Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Dow
Colorcon
McKesson
Johnson and Johnson

Last Updated: December 3, 2022

IMODIUM A-D Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Imodium A-d, and what generic alternatives are available?

Imodium A-d is a drug marketed by J And J Consumer Inc and is included in three NDAs.

The generic ingredient in IMODIUM A-D is loperamide hydrochloride. There are eleven drug master file entries for this compound. Ninety-seven suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Imodium A-d

A generic version of IMODIUM A-D was approved as loperamide hydrochloride by MYLAN on September 18th, 1991.

  Try it Free

Summary for IMODIUM A-D
Drug patent expirations by year for IMODIUM A-D
Drug Sales Revenue Trends for IMODIUM A-D

See drug sales revenues for IMODIUM A-D

Recent Clinical Trials for IMODIUM A-D

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
MedSIRPhase 2
Gilead SciencesPhase 2
Naia PharmaceuticalsPhase 1/Phase 2

See all IMODIUM A-D clinical trials

Pharmacology for IMODIUM A-D
Drug ClassOpioid Agonist
Mechanism of Action Opioid Agonists

US Patents and Regulatory Information for IMODIUM A-D

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc IMODIUM A-D loperamide hydrochloride SOLUTION;ORAL 019487-001 Mar 1, 1988 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc IMODIUM A-D EZ CHEWS loperamide hydrochloride TABLET, CHEWABLE;ORAL 020448-001 Jul 24, 1997 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc IMODIUM A-D loperamide hydrochloride SUSPENSION;ORAL 019487-002 Jul 8, 2004 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc IMODIUM A-D loperamide hydrochloride TABLET;ORAL 019860-001 Nov 22, 1989 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for IMODIUM A-D

See the table below for patents covering IMODIUM A-D around the world.

Country Patent Number Title Estimated Expiration
Japan S5914467 See Plans and Pricing
Czechoslovakia 171232 METHOD OF 2,2-DIARYL-4-(4'-ARYL-4'-HYDROXYPIPERIDINO) BUTYRAMIDES PRODUCTION See Plans and Pricing
Netherlands 7106829 See Plans and Pricing
Finland 762133 See Plans and Pricing
Finland 54472 See Plans and Pricing
Hong Kong 78076 2,2-DIARYL-4-(4-ARYL-4-HYDROXY-PIPERIDINO)-BUTYRAMIDES See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for IMODIUM A-D

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0428296 SPC/GB98/013 United Kingdom See Plans and Pricing PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
McKesson
Merck
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.